메뉴 건너뛰기




Volumn 95, Issue 11, 2005, Pages 1314-1319

Cost effectiveness of rosuvastatin in treating patients to low-density lipoprotein cholesterol goals compared with atorvastatin, pravastatin, and simvastatin (a US analysis of the STELLAR Trial)

Author keywords

[No Author keywords available]

Indexed keywords

ANTILIPEMIC AGENT; ATORVASTATIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PRAVASTATIN; ROSUVASTATIN; SIMVASTATIN;

EID: 19344364626     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2005.01.074     Document Type: Article
Times cited : (26)

References (26)
  • 1
    • 0038645309 scopus 로고    scopus 로고
    • Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvastatin, and pravastatin across doses (STELLAR trial)
    • STELLAR Study Group J.W.
    • P.H. Jones, M.H. Davidson, E.A. Stein, H.E. Bays, J.M. McKenney, E. Miller, V.A. Cain, J.W. Blasetto STELLAR Study Group Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvastatin, and pravastatin across doses (STELLAR trial) Am J Cardiol 92 2003 152 160
    • (2003) Am J Cardiol , vol.92 , pp. 152-160
    • Jones, P.H.1    Davidson, M.H.2    Stein, E.A.3    Bays, H.E.4    McKenney, J.M.5    Miller, E.6    Cain, V.A.7    Blasetto8
  • 2
    • 19344367431 scopus 로고    scopus 로고
    • First DataBank. June
    • First DataBank. June 2004. Available at: www.firstdatabank.com. Accessed on June 8, 2004.
    • (2004)
  • 3
    • 0036910821 scopus 로고    scopus 로고
    • Efficacy and safety of rosuvastatin compared with pravastatin and simvastatin in patients with hypercholesterolemia: a randomized, double-blind, 52-week trial
    • Rosuvastatin Study Group E.
    • W.V. Brown, H.E. Bays, D.R. Hassman, J. McKenney, R. Chitra, H. Hutchinson, E. Miller Rosuvastatin Study Group Efficacy and safety of rosuvastatin compared with pravastatin and simvastatin in patients with hypercholesterolemia: a randomized, double-blind, 52-week trial Am Heart J 144 2002 1036 1043
    • (2002) Am Heart J , vol.144 , pp. 1036-1043
    • Brown, W.V.1    Bays, H.E.2    Hassman, D.R.3    McKenney, J.4    Chitra, R.5    Hutchinson, H.6    Miller7
  • 4
    • 0036915307 scopus 로고    scopus 로고
    • Effects of rosuvastatin and atorvastatin compared over 52 weeks of treatment in patients with hypercholesterolemia
    • Rosuvastatin Investigators Group J.W.
    • A.G. Olsson, H. Istad, O. Luurila, L. Ose, S. Stender, J. Tuomilehto, O. Wiklund, H. Southworth, J. Pears, J.W. Wilpshaar Rosuvastatin Investigators Group Effects of rosuvastatin and atorvastatin compared over 52 weeks of treatment in patients with hypercholesterolemia Am Heart J 144 2002 1044 1051
    • (2002) Am Heart J , vol.144 , pp. 1044-1051
    • Olsson, A.G.1    Istad, H.2    Luurila, O.3    Ose, L.4    Stender, S.5    Tuomilehto, J.6    Wiklund, O.7    Southworth, H.8    Pears, J.9    Wilpshaar10
  • 6
    • 0001994993 scopus 로고    scopus 로고
    • Handling uncertainty in economic evaluation and presenting the results
    • M. Drummond A. McGuire Oxford University Press/Office of Health Economics Oxford
    • A. Briggs Handling uncertainty in economic evaluation and presenting the results M. Drummond A. McGuire Economic Evaluation in Health Care--Merging Theory With Practice 2001 Oxford University Press/Office of Health Economics Oxford 172 214
    • (2001) Economic Evaluation in Health Care--Merging Theory With Practice , pp. 172-214
    • Briggs, A.1
  • 7
    • 0031900689 scopus 로고    scopus 로고
    • Net health benefits: a new framework for the analysis of uncertainty in cost-effectiveness analysis
    • A.A. Stinnett, J. Mullahy Net health benefits: a new framework for the analysis of uncertainty in cost-effectiveness analysis Med Decis Making 18 suppl 1998 S68 S80
    • (1998) Med Decis Making , vol.18 , Issue.SUPPL.
    • Stinnett, A.A.1    Mullahy, J.2
  • 9
    • 1542437305 scopus 로고    scopus 로고
    • Determinants of the cost-effectiveness of statins
    • A. Morrison, H. Glassberg Determinants of the cost-effectiveness of statins J Manag Care Pharm 9 2003 544 551
    • (2003) J Manag Care Pharm , vol.9 , pp. 544-551
    • Morrison, A.1    Glassberg, H.2
  • 11
    • 0033198903 scopus 로고    scopus 로고
    • Comparative cost-effectiveness of HMG-CoA reductase inhibitors in secondary prevention of acute myocardial infarction
    • W.J. Elliott, D.R. Weir Comparative cost-effectiveness of HMG-CoA reductase inhibitors in secondary prevention of acute myocardial infarction Am J Health Syst Pharm 56 1999 1726 1732
    • (1999) Am J Health Syst Pharm , vol.56 , pp. 1726-1732
    • Elliott, W.J.1    Weir, D.R.2
  • 12
    • 0037422116 scopus 로고    scopus 로고
    • Efficacy of rosuvastatin compared with other statins at selected starting doses in hypercholesterolemic patients and in special population groups
    • J.W. Blasetto, E.A. Stein, W.V. Brown, R. Chitra, A. Raza Efficacy of rosuvastatin compared with other statins at selected starting doses in hypercholesterolemic patients and in special population groups Am J Cardiol 91 suppl 5A 2003 3C 10C
    • (2003) Am J Cardiol , vol.91 , Issue.SUPPL. 5A
    • Blasetto, J.W.1    Stein, E.A.2    Brown, W.V.3    Chitra, R.4    Raza, A.5
  • 13
    • 0037422072 scopus 로고    scopus 로고
    • Guidelines for lowering lipids to reduce coronary artery disease risk: a comparison of rosuvastatin with atorvastatin, pravastatin, and simvastatin for achieving lipid-lowering goals
    • J. Shepherd, D.B. Hunninghake, P. Barter, J.M. McKenney, H.G. Hutchinson Guidelines for lowering lipids to reduce coronary artery disease risk: a comparison of rosuvastatin with atorvastatin, pravastatin, and simvastatin for achieving lipid-lowering goals Am J Cardiol 91 suppl 2003 11C 19C
    • (2003) Am J Cardiol , vol.91 , Issue.SUPPL.
    • Shepherd, J.1    Hunninghake, D.B.2    Barter, P.3    McKenney, J.M.4    Hutchinson, H.G.5
  • 14
    • 0030967489 scopus 로고    scopus 로고
    • Comparison of one-year efficacy and safety of atorvastatin versus lovastatin in primary hypercholesterolemia: Atorvastatin Study Group I
    • M. Davidson, J. McKenney, E. Stein, H. Schrott, R. Bakker-Arkema, R. Fayyad, D. Black Comparison of one-year efficacy and safety of atorvastatin versus lovastatin in primary hypercholesterolemia Atorvastatin Study Group I Am J Cardiol 79 1997 1475 1481
    • (1997) Am J Cardiol , vol.79 , pp. 1475-1481
    • Davidson, M.1    McKenney, J.2    Stein, E.3    Schrott, H.4    Bakker-Arkema, R.5    Fayyad, R.6    Black, D.7
  • 15
    • 0037223771 scopus 로고    scopus 로고
    • Comparative effects of rosuvastatin and atorvastatin across their dose ranges in patients with hypercholesterolemia and without active arterial disease
    • D.W. Schneck, R.H. Knopp, C.M. Ballantyne, R. McPherson, R.R. Chitra, S.G. Simonson Comparative effects of rosuvastatin and atorvastatin across their dose ranges in patients with hypercholesterolemia and without active arterial disease Am J Cardiol 91 2003 33 41
    • (2003) Am J Cardiol , vol.91 , pp. 33-41
    • Schneck, D.W.1    Knopp, R.H.2    Ballantyne, C.M.3    McPherson, R.4    Chitra, R.R.5    Simonson, S.G.6
  • 16
    • 2542582855 scopus 로고    scopus 로고
    • Effects of switching statins on achievement of lipid goals: Measuring Effective Reductions in Cholesterol Using Rosuvastatin Therapy (MERCURY I) study
    • MERCURY I Study Group A.
    • H. Schuster, P.J. Barter, S. Stender, R.C. Cheung, J. Bonnet, J.M. Morrell, C. Watkins, D. Kallend, A. Raza MERCURY I Study Group Effects of switching statins on achievement of lipid goals Measuring Effective Reductions in Cholesterol Using Rosuvastatin Therapy (MERCURY I) study Am Heart J 147 2004 705 713
    • (2004) Am Heart J , vol.147 , pp. 705-713
    • Schuster, H.1    Barter, P.J.2    Stender, S.3    Cheung, R.C.4    Bonnet, J.5    Morrell, J.M.6    Watkins, C.7    Kallend, D.8    Raza9
  • 17
    • 0034723758 scopus 로고    scopus 로고
    • The Lipid Treatment Assessment Project (L-TAP): a multicenter survey to evaluate the percentages of dyslipidemic patients receiving lipid-lowering therapy and achieving low-density lipoprotein cholesterol goals
    • T.A. Pearson, I. Laurora, H. Chu, S. Kafonek The Lipid Treatment Assessment Project (L-TAP): a multicenter survey to evaluate the percentages of dyslipidemic patients receiving lipid-lowering therapy and achieving low-density lipoprotein cholesterol goals Arch Intern Med 160 2000 459 467
    • (2000) Arch Intern Med , vol.160 , pp. 459-467
    • Pearson, T.A.1    Laurora, I.2    Chu, H.3    Kafonek, S.4
  • 19
    • 0036467895 scopus 로고    scopus 로고
    • Comparison of effects on low-density lipoprotein cholesterol and high-density lipoprotein cholesterol with rosuvastatin versus atorvastatin in patients with type IIa or IIb hypercholesterolemia
    • M. Davidson, P. Ma, E.A. Stein, A.M. Gotto Jr, A. Raza, R. Chitra, H. Hutchinson Comparison of effects on low-density lipoprotein cholesterol and high-density lipoprotein cholesterol with rosuvastatin versus atorvastatin in patients with type IIa or IIb hypercholesterolemia Am J Cardiol 89 2002 268 275
    • (2002) Am J Cardiol , vol.89 , pp. 268-275
    • Davidson, M.1    Ma, P.2    Stein, E.A.3    Gotto A.M. Jr4    Raza, A.5    Chitra, R.6    Hutchinson, H.7
  • 20
    • 3042794762 scopus 로고    scopus 로고
    • Safety and efficacy of rosuvastatin
    • G.O. Olsson Safety and efficacy of rosuvastatin Lancet 364 2004 135
    • (2004) Lancet , vol.364 , pp. 135
    • Olsson, G.O.1
  • 21
    • 0027987849 scopus 로고
    • Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)
    • Scandinavian Simvastatin Survival Study Group
    • Scandinavian Simvastatin Survival Study Group Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S) Lancet 344 1994 1383 1389
    • (1994) Lancet , vol.344 , pp. 1383-1389
  • 22
    • 0028883828 scopus 로고
    • Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia: West of Scotland Coronary Prevention Study Group
    • J. Shepherd, S.M. Cobbe, I. Ford, C.G. Isles, A.R. Lorimer, P.W. MacFarlane, J.H. McKillop, C.J. Packard Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia West of Scotland Coronary Prevention Study Group N Engl J Med 333 1995 1301 1307
    • (1995) N Engl J Med , vol.333 , pp. 1301-1307
    • Shepherd, J.1    Cobbe, S.M.2    Ford, I.3    Isles, C.G.4    Lorimer, A.R.5    MacFarlane, P.W.6    McKillop, J.H.7    Packard, C.J.8
  • 23
    • 0342981862 scopus 로고    scopus 로고
    • The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels: Cholesterol and Recurrent Events Trial investigators
    • F.M. Sacks, M.A. Pfeffer, L.A. Moye, J.L. Rouleau, J.D. Rutherford, T.G. Cole, L. Brown, J.W. Warnica, J.M. Arnold, C.C. Wun The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels Cholesterol and Recurrent Events Trial investigators N Engl J Med 335 1996 1001 1009
    • (1996) N Engl J Med , vol.335 , pp. 1001-1009
    • Sacks, F.M.1    Pfeffer, M.A.2    Moye, L.A.3    Rouleau, J.L.4    Rutherford, J.D.5    Cole, T.G.6    Brown, L.7    Warnica, J.W.8    Arnold, J.M.9    Wun, C.C.10
  • 24
    • 0032572086 scopus 로고    scopus 로고
    • Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: Results of AFCAPS/TexCAPS
    • AFCAPS/TexCAPS Research Group
    • J.R. Downs, M. Clearfield, S. Weis, E. Whitney, D.R. Shapiro, P.A. Beere, A. Langendorfer, E.A. Stein, W. Kruyer, A.M. Gotto Jr AFCAPS/TexCAPS Research Group Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels Results of AFCAPS/TexCAPS JAMA 279 1998 1615 1622
    • (1998) JAMA , vol.279 , pp. 1615-1622
    • Downs, J.R.1    Clearfield, M.2    Weis, S.3    Whitney, E.4    Shapiro, D.R.5    Beere, P.A.6    Langendorfer, A.7    Stein, E.A.8    Kruyer, W.9    Gotto A.M. Jr10
  • 25
    • 0037031061 scopus 로고    scopus 로고
    • MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial
    • Heart Protection Study Collaborative Group
    • Heart Protection Study Collaborative Group MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial Lancet 360 2002 7 22
    • (2002) Lancet , vol.360 , pp. 7-22
  • 26
    • 0037178569 scopus 로고    scopus 로고
    • Fluvastatin for prevention of cardiac events following successful first percutaneous coronary intervention: a randomized controlled trial
    • Lescol Intervention Prevention Study (LIPS) Investigators B.
    • P.W. Serruys, P. de Feyter, C. Macaya, N. Kokott, J. Puel, M. Vrolix, A. Branzi, M.C. Bertolami, G. Jackson, B. Strauss, B. Meier Lescol Intervention Prevention Study (LIPS) Investigators Fluvastatin for prevention of cardiac events following successful first percutaneous coronary intervention: a randomized controlled trial JAMA 287 2002 3215 3222
    • (2002) JAMA , vol.287 , pp. 3215-3222
    • Serruys, P.W.1    De Feyter, P.2    Macaya, C.3    Kokott, N.4    Puel, J.5    Vrolix, M.6    Branzi, A.7    Bertolami, M.C.8    Jackson, G.9    Strauss, B.10    Meier11


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.